BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1361113)

  • 1. Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin.
    Fuxe K; Von Euler G; Agnati LF; Merlo Pich E; O'Connor WT; Tanganelli S; Li XM; Tinner B; Cintra A; Carani C
    Ann N Y Acad Sci; 1992; 668():186-204. PubMed ID: 1361113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia.
    Antonelli T; Tomasini MC; Fuxe K; Agnati LF; Tanganelli S; Ferraro L
    J Neural Transm (Vienna); 2007 Jan; 114(1):105-13. PubMed ID: 16983483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum.
    Fuxe K; O'Connor WT; Antonelli T; Osborne PG; Tanganelli S; Agnati LF; Ungerstedt U
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5591-5. PubMed ID: 1535159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current status of neurotensin-dopamine interactions. Issues and speculations.
    Deutch AY; Zahm DS
    Ann N Y Acad Sci; 1992; 668():232-52. PubMed ID: 1361115
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence.
    von Euler G; Meister B; Hökfelt T; Eneroth P; Fuxe K
    Brain Res; 1990 Oct; 531(1-2):253-62. PubMed ID: 1981163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia.
    Ferraro L; Beggiato S; Borroto-Escuela DO; Ravani L; O'Connor WT; Tomasini MC; Borelli AC; Agnati LF; Antonelli T; Tanganelli S; Fuxe K
    Curr Protein Pept Sci; 2014; 15(7):681-90. PubMed ID: 25175457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study.
    Li XM; Ferraro L; Tanganelli S; O'Connor WT; Hasselrot U; Ungerstedt U; Fuxe K
    J Neural Transm Gen Sect; 1995; 102(2):125-37. PubMed ID: 8748677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromedin N is a potent modulator of dopamine D2 receptor agonist binding in rat neostriatal membranes.
    Li XM; Finnman UB; von Euler G; Hedlund PB; Fuxe K
    Neurosci Lett; 1993 Jun; 155(2):121-4. PubMed ID: 8104321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin and cholecystokinin octapeptide control synergistically dopamine release and dopamine D2 receptor affinity in rat neostriatum.
    Tanganelli S; Li XM; Ferraro L; Von Euler G; O'Connor WT; Bianchi C; Beani L; Fuxe K
    Eur J Pharmacol; 1993 Jan; 230(2):159-66. PubMed ID: 8422898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist.
    Díaz-Cabiale Z; Fuxe K; Narváez JA; Finetti S; Antonelli T; Tanganelli S; Ferraro L
    Neuroreport; 2002 May; 13(6):763-6. PubMed ID: 11997683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
    Prus AJ; Schuck CJ; Rusch KR; Carey LM
    Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of neuroleptic activity of 9,10-didehydro-N-methyl-(2-propynyl)-6-methyl-8-aminomethylergoline bimaleinate (LEK-8829) by D1 intrinsic activity in hemi-parkinsonian rats.
    Glavan G; Sket D; Zivin M
    Mol Pharmacol; 2002 Feb; 61(2):360-8. PubMed ID: 11809861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesocortical dopamine-neurotensin neurons. Possible opposite role of noradrenergic pathways on heteroregulations of dopamine (D1) and neurotensin postsynaptic receptors in the rat prefrontal cortex.
    Tassin JP; Trovero F; Hervé D; Blanc G; Glowinski J
    Ann N Y Acad Sci; 1992; 668():205-16. PubMed ID: 1334386
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.
    Masuo Y; Montagne MN; Pélaprat D; Scherman D; Rostène W
    Brain Res; 1990 Jun; 520(1-2):6-13. PubMed ID: 2169955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of the intramembrane interaction between neurotensin and dopamine D2 receptors in the rat brain.
    von Euler G
    Brain Res; 1991 Oct; 561(1):93-8. PubMed ID: 1839140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin Induces Presynaptic Depression of D2 Dopamine Autoreceptor-Mediated Neurotransmission in Midbrain Dopaminergic Neurons.
    Piccart E; Courtney NA; Branch SY; Ford CP; Beckstead MJ
    J Neurosci; 2015 Aug; 35(31):11144-52. PubMed ID: 26245975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mephedrone alters basal ganglia and limbic neurotensin systems.
    German CL; Hoonakker AH; Fleckenstein AE; Hanson GR
    J Neurochem; 2014 Aug; 130(3):402-7. PubMed ID: 24678634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.